These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HIV type 1 integrase inhibitors: from basic research to clinical implications. Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; QuiƱones-Mateu M AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase. Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 integrase inhibitors: 2003-2004 update. Dayam R; Deng J; Neamati N Med Res Rev; 2006 May; 26(3):271-309. PubMed ID: 16496343 [TBL] [Abstract][Full Text] [Related]
6. Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds. Maes M; Levin A; Hayouka Z; Shalev DE; Loyter A; Friedler A Bioorg Med Chem; 2009 Nov; 17(22):7635-42. PubMed ID: 19850483 [TBL] [Abstract][Full Text] [Related]
7. HIV integrase as a target for antiviral chemotherapy. Nair V Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143 [TBL] [Abstract][Full Text] [Related]
8. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829 [TBL] [Abstract][Full Text] [Related]
9. HIV integrase inhibitors as therapeutic agents in AIDS. Nair V; Chi G Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547 [TBL] [Abstract][Full Text] [Related]
10. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series. De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342 [TBL] [Abstract][Full Text] [Related]
11. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors. Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974 [TBL] [Abstract][Full Text] [Related]
12. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection. Lin SS; Xu F; Liao PH; Yang CC Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475 [TBL] [Abstract][Full Text] [Related]
13. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy. McColl DJ; Chen X Antiviral Res; 2010 Jan; 85(1):101-18. PubMed ID: 19925830 [TBL] [Abstract][Full Text] [Related]
14. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407 [TBL] [Abstract][Full Text] [Related]
16. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance. Lataillade M; Chiarella J; Kozal MJ Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566 [TBL] [Abstract][Full Text] [Related]
17. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer. Voet AR; Maeyer MD; Debyser Z; Christ F Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors. Meadows DC; Mathews TB; North TW; Hadd MJ; Kuo CL; Neamati N; Gervay-Hague J J Med Chem; 2005 Jul; 48(14):4526-34. PubMed ID: 15999991 [TBL] [Abstract][Full Text] [Related]
19. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores. Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623 [TBL] [Abstract][Full Text] [Related]
20. Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones. Gardelli C; Nizi E; Muraglia E; Crescenzi B; Ferrara M; Orvieto F; Pace P; Pescatore G; Poma M; Ferreira Mdel R; Scarpelli R; Homnick CF; Ikemoto N; Alfieri A; Verdirame M; Bonelli F; Paz OG; Taliani M; Monteagudo E; Pesci S; Laufer R; Felock P; Stillmock KA; Hazuda D; Rowley M; Summa V J Med Chem; 2007 Oct; 50(20):4953-75. PubMed ID: 17824681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]